These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 1503012)

  • 41. Pathological axillary lymph nodes detected at mammographic screening.
    Lim ET; O'Doherty A; Hill AD; Quinn CM
    Clin Radiol; 2004 Jan; 59(1):86-91. PubMed ID: 14697380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Additional images and subsequent palpation--indispensable conditions for efficient diagnosis using mammography].
    Hüppe JR
    Z Lymphol; 1986 Dec; 10(2):63-76. PubMed ID: 3825243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic value of xero-mammography in clinically occult breast carcinoma.
    Kambouris T; Kotoulas K; Pontifex G
    Radiologe; 1984 May; 24(5):230-4. PubMed ID: 6087403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography.
    Ko EY; Han BK; Shin JH; Kang SS
    Korean J Radiol; 2007; 8(5):382-9. PubMed ID: 17923780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients.
    Krecke KN; Gisvold JJ
    AJR Am J Roentgenol; 1993 Nov; 161(5):957-60. PubMed ID: 8273634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review.
    de Bresser J; de Vos B; van der Ent F; Hulsewé K
    Eur J Surg Oncol; 2010 Feb; 36(2):114-9. PubMed ID: 19822403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.
    Valente SA; Levine GM; Silverstein MJ; Rayhanabad JA; Weng-Grumley JG; Ji L; Holmes DR; Sposto R; Sener SF
    Ann Surg Oncol; 2012 Jun; 19(6):1825-30. PubMed ID: 22227922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sonographic evaluation of isolated abnormal axillary lymph nodes identified on mammograms.
    Shetty MK; Carpenter WS
    J Ultrasound Med; 2004 Jan; 23(1):63-71. PubMed ID: 14756355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRI in patients with axillary metastases of occult breast carcinoma.
    Tilanus-Linthorst MM; Obdeijn AI; Bontenbal M; Oudkerk M
    Breast Cancer Res Treat; 1997 Jun; 44(2):179-82. PubMed ID: 9232276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Axillary metastasis from occult breast carcinoma: diagnosis and management.
    Jackson B; Scott-Conner C; Moulder J
    Am Surg; 1995 May; 61(5):431-4. PubMed ID: 7733550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occult breast carcinoma presenting as axillary metastases.
    Foroudi F; Tiver KW
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):143-7. PubMed ID: 10758316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of clinically occult and mammographically occult breast tumors.
    Feig SA; Shaber GS; Patchefsky A; Schwartz GF; Edeiken J; Libshitz HI; Nerlinger R; Curley RF; Wallace JD
    AJR Am J Roentgenol; 1977 Mar; 128(3):403-8. PubMed ID: 190908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is screening detected bilateral axillary adenopathy on mammography clinically significant?
    Chetlen A; Nicholson B; Patrie JT; Harvey JA
    Breast J; 2012; 18(6):582-7. PubMed ID: 23078417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
    Roubidoux MA; Bailey JE; Wray LA; Helvie MA
    Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tubular carcinoma of the breast: mammographic appearance.
    Leibman AJ; Lewis M; Kruse B
    AJR Am J Roentgenol; 1993 Feb; 160(2):263-5. PubMed ID: 8424330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential diagnosis of axillary masses.
    de Andrade JM; Marana HR; Sarmento Filho JM; Murta EF; Velludo MA; Bighetti S
    Tumori; 1996; 82(6):596-9. PubMed ID: 9061072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory breast carcinoma: mammographic findings.
    Dershaw DD; Moore MP; Liberman L; Deutch BM
    Radiology; 1994 Mar; 190(3):831-4. PubMed ID: 8115635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.